NEW YORK, New York - As Older Americans Month and Mother’s Day align this May, Touching Hearts NYC redefines the standard of senior in-home care across New York City. Their 24-hour in-home care services go beyond basic needs, blending practical support with heartfelt companionship into every visit to ensure seniors feel genuinely valued as they age. In a city where 1 in 4 seniors experiences loneliness - and 30% live alone, according to The NYC Aging Department - Touching Hearts NYC demonstrates how senior in-home care transforms isolation into meaningful connection while honoring each senior's unique legacy.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
While the S&P 500 includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
While the S&P 500 includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
(BPT) - What is it like for millions of American families managing food allergies? To better understand these experiences, Genentech, a member of the Roche Group, and the Novartis Pharmaceuticals Corporation partnered with The Harris Poll to survey U.S. parents and guardians of children with food allergies. Explore the findings in this infographic to uncover the impact of food allergies and how increased awareness, education, and support can help affected families. If you or your child have food allergies, schedule an appointment with an allergist to discuss your options.
Spring Hill, TN - Capital Business Solutions, a leading provider of financial software solutions for nonprofits, is proud to announce that its newest app, NXT Time, is now officially listed on the Blackbaud Marketplace. This milestone marks a significant step forward in optimizing time-tracking and payroll integration for nonprofit accountants using Financial Edge NXT.
Exploring WASTE MANAGEMENT INC's Technical Signals and Breakout Potential: WASTE MANAGEMENT INC is showing promising signs of setting up for a breakout.
Blackstone (BX) reports strong Q1 results, with revenues of $2.763B (+8% Y/Y) and DE of $1.41B (+11% Y/Y). AUM rises to $1.17T, with inflows of $61.6B. BX also declares a dividend and has $9.8B in cash.
HAEMONETICS CORP/MASS has caught the attention as a great value stock. NYSE:HAE excels in profitability, solvency, and liquidity, all while being very reasonably priced.
American Express reported strong Q1 2025 results, with revenue of $16.97B, up 7% YoY, and GAAP EPS of $3.64, beating analyst estimates. Outlook remains positive despite macroeconomic environment.
The company says orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist to successfully complete a Phase 3 trial.
Water control and measure company Badger Meter (NYSE:BMI) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 13.2% year on year to $222.2 million. Its GAAP profit of $1.30 per share was 26.4% above analysts’ consensus estimates.
